# Normoxemic Versus Hyperoxemic Extracorporeal Oxygenation in Patients Supported by Veino-arterial ECMO for Cardiogenic Shock

> **NCT04990349** · PHASE3 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 60 (actual)

## Conditions studied

- Cardiogenic Shock
- Extracorporeal Membrane Oxygenation

## Interventions

- **DRUG:** Oxygen gas

## Key facts

- **NCT ID:** NCT04990349
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-09
- **Primary completion:** 2023-11-10
- **Final completion:** 2023-12-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04990349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04990349, "Normoxemic Versus Hyperoxemic Extracorporeal Oxygenation in Patients Supported by Veino-arterial ECMO for Cardiogenic Shock". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04990349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*